Literature DB >> 25908922

Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer.

S F Hall1, J C Irish2, R W Gregg3, P A Groome4, S Rohland4.   

Abstract

BACKGROUND: Clinical practice guidelines (cpgs) are systematically developed statements designed to assist practitioners and patients in making decisions about appropriate heath care interventions. Clinical practice guidelines are expensive and time-consuming to create. A cpg on concurrent chemotherapy with radiation therapy (ccrt) was developed in Ontario at a time when treatment approaches for head-and-neck cancer were changing significantly.
METHODS: An assessment of treatments and outcomes based on electronic and chart data obtained from a population-based study of 571 patients with oropharynx cancer treated in Ontario (2003-2004) was combined with a review of relevant knowledge transfer (publications and presentations at major meetings) to understand variation in adherence to a cpg.
RESULTS: In 9 Ontario cancer treatment centres, ccrt was used for 55% of all patients with oropharyngeal cancer; however, at the centres individually, that proportion ranged from 82% to 39%. Furthermore, there was no agreement on the chemotherapy regimen: 2-4 years later (a period during which newer regimens were emerging), only 4 of 9 centres were following the guideline for most patients. When outcomes of treated patients were compared for centres with "higher" and "lower" use of ccrt, no difference in survival was observed (p = 0.64).
CONCLUSIONS: At a time of treatment evolution, the new guideline was controversial, and there are many reasons for the mixed adherence. An estimation of adherence should be included during both development and review of guidelines.

Entities:  

Keywords:  Clinical practice guidelines; chemoradiotherapy; head-and-neck cancer; uptake; variation

Year:  2015        PMID: 25908922      PMCID: PMC4399625          DOI: 10.3747/co.22.2235

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  32 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 2.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

3.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

Review 4.  Clinical practice guidelines: a critical review.

Authors:  Keng Boon Harold Tan
Journal:  Int J Health Care Qual Assur Inc Leadersh Health Serv       Date:  2006

Review 5.  Effects of evidence-based clinical practice guidelines on quality of care: a systematic review.

Authors:  M Lugtenberg; J S Burgers; G P Westert
Journal:  Qual Saf Health Care       Date:  2009-10

Review 6.  Knowledge creation: synthesis, tools and products.

Authors:  Melissa Brouwers; Dawn Stacey; Annette O'Connor
Journal:  CMAJ       Date:  2009-11-02       Impact factor: 8.262

7.  Evaluation of treatment benefit in Journal of Clinical Oncology.

Authors:  Pamela J Goodwin; Karla V Ballman; Eric J Small; Stephen A Cannistra
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

Review 8.  Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways.

Authors:  T J Smith; B E Hillner
Journal:  J Clin Oncol       Date:  2001-06-01       Impact factor: 44.544

Review 9.  Dysphagia following chemoradiation for locally advanced head and neck cancer.

Authors:  N P Nguyen; C C Moltz; C Frank; P Vos; H J Smith; U Karlsson; S Dutta; F A Midyett; J Barloon; S Sallah
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

10.  Prognostic importance of comorbidity in a hospital-based cancer registry.

Authors:  Jay F Piccirillo; Ryan M Tierney; Irene Costas; Lori Grove; Edward L Spitznagel
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  9 in total

1.  Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study.

Authors:  A L Mahar; L E Davis; L D Bubis; Q Li; R Sutradhar; N G Coburn; L Barbera
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

2.  Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.

Authors:  Milena A Gianfrancesco; Gabriela Schmajuk; Sarah Haserodt; Laura Trupin; Zara Izadi; Kashif Jafri; Stephen Shiboski; Marina Sirota; Jinoos Yazdany
Journal:  Rheumatol Int       Date:  2017-07-26       Impact factor: 2.631

3.  Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.

Authors:  Edmund A Mroz; Krupal B Patel; James W Rocco
Journal:  Cancer       Date:  2020-02-21       Impact factor: 6.860

Review 4.  Implementation of study results in guidelines and adherence to guidelines in clinical practice.

Authors:  Frank Waldfahrer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

5.  Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.

Authors:  Stephen F Hall; Fei-Fei Liu; Brian O'Sullivan; Willa Shi; Susan Rohland; Rebecca Griffiths; Patti Groome
Journal:  Br J Cancer       Date:  2017-08-22       Impact factor: 7.640

6.  Feedback preferences of patients, professionals and health insurers in integrated head and neck cancer care.

Authors:  Lydia F J van Overveld; Robert P Takes; Thomas W Vijn; Jozé C C Braspenning; Jan P de Boer; John J A Brouns; Rolf J Bun; Boukje A C van Dijk; Judith A W F Dortmans; Emilie A C Dronkers; Robert J J van Es; Frank J P Hoebers; Arvid Kropveld; Johannes A Langendijk; Ton P M Langeveld; Sjoukje F Oosting; Hendrik P Verschuur; Jan G A M de Visscher; Stijn van Weert; Matthias A W Merkx; Ludi E Smeele; Rosella P M G Hermens
Journal:  Health Expect       Date:  2017-06-15       Impact factor: 3.377

7.  The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.

Authors:  Stephen F Hall; Rebecca J Griffiths; Brian O'Sullivan; Fei-Fei Liu
Journal:  Head Neck       Date:  2019-02-04       Impact factor: 3.147

Review 8.  Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy.

Authors:  Morena Fasano; Ida D'Onofrio; Maria Paola Belfiore; Antonio Angrisani; Valentina Caliendo; Carminia Maria Della Corte; Mario Pirozzi; Sergio Facchini; Marianna Caterino; Cesare Guida; Valerio Nardone; Alfonso Reginelli; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

9.  Customized registry tool for tracking adherence to clinical guidelines for head and neck cancers: protocol for a pilot study.

Authors:  Matthew D Hickey; Sarah Lisker; Shauna Brodie; Eric Vittinghoff; Marika D Russell; Urmimala Sarkar
Journal:  Pilot Feasibility Stud       Date:  2020-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.